Last edition
News about "Senores Pharmaceuticals "
Senores Pharmaceuticals Q1 FY27 Revenue Grows 35.9 Percent YoY to INR 180.2 Crore
Senores Pharmaceuticals reported 35.9 percent Year over Year (YoY) revenue growth to INR 180.2 crore in Q1 FY27, driven by regulated and emerging markets and higher profitability.
Senores Pharmaceuticals | 27/07/2026 | By News Bureau | 127
Senores Pharmaceuticals to Acquire Apnar Pharma and Five ANDAs
Senores Pharmaceuticals has entered into an agreement to acquire 100 percent equity in Apnar Pharma, along with a portfolio of five Abbreviated New Drug Applications (ANDAs), as part of its strategy to expand its footprint in regulated pharmaceutical markets.
Senores Pharmaceuticals | 18/12/2025 | By Darshana | 250
Senores Pharmaceuticals Inks SPA to Raise Stake in Havix
Senores Pharmaceuticals Ltd. (SPL) has entered into a Share Purchase Agreement (SPA) with a public shareholder of Havix Group Inc., doing business as Aavis Pharmaceuticals (Havix), to acquire 6,730 equity shares — representing 2.97 percent of Havix’s total paid-up share capital.
Senores Pharmaceuticals | 14/07/2025 | By Dineshwori | 453
Senores Pharmaceuticals Strengthens Global Presence with New USFDA Approvals
The acquisition includes 13 ANDAs that have already received approval from the US Food and Drug Administration (USFDA) and one ANDA that is currently pending approval.
Senores Pharmaceuticals | 05/03/2025 | By Aishwarya | 712
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy